Search clinical trials for: Haematological malignancy
Total 1336 results
-
Beni-Suef UniversityRecruiting
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
University Hospital, MontpellierRecruiting
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Massachusetts General HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Solid MalignancyUnited States
-
Masonic Cancer Center, University of MinnesotaRecruitingLymphatic Diseases | Hematopoietic MalignancyUnited States
-
Oregon Health and Science UniversityRecruiting
-
St. Jude Children's Research HospitalRecruitingMucopolysaccharidosis I | Severe Combined Immunodeficiency | Neuroblastoma | Neoplasm | Malignancy, HematologicUnited States
-
Bausch Health Americas, Inc.Clinical Research Computing Unit (University of Pennsylvania)RecruitingAtopic DermatitisUnited States
-
National Cancer Institute (NCI)RecruitingBreast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer | Liver CancerUnited States
-
Zimmer BiometCompleted
-
National Cancer Institute (NCI)Lymphoma/Leukemia Molecular Profiling Project (LLMPP)CompletedLymphoma, Non-Hodgkin | Leukemia | Multiple Myeloma | Hodgkin LymphomaUnited States
-
Cedars-Sinai Medical CenterActive, not recruitingLymphoma | Leukemia | Cancer | Breast Cancer | Prostate Cancer | Hematologic Malignancy | Thyroid Cancer | Non-hodgkin LymphomaUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
National Cancer Institute (NCI)Active, not recruitingHIV | Lymphoproliferative Disorder | Malignancy | HHV-8United States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell... and other conditionsUnited States, Guam
-
AstraZenecaCompletedNeoplasms | AsthmaSweden, United Kingdom
-
University of ArizonaCompletedBreast Cancer | Chronic Pain Due to Malignancy (Finding)United States
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma | Hematologic Malignancy | Solid Tumor MalignancyUnited States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States, Australia
-
National Cancer Institute (NCI)Enrolling by invitationMelanoma | Pancreatic Cancer | Lung Cancer | Solid Tumors | Gastrointestinal Cancer | Hematologic Malignancy | Liver Cancer | Pre-MalignancyUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationHealthy Volunteer | Hematologic Disease and Disorders | DonorsUnited States
-
Phoenix Molecular DesignsActive, not recruitingMetastatic Breast CancerUnited States
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
AstraZenecaCompletedHypereosinophilic Syndrome (HES)United States
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-ConfirmedUnited States
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
Brigham and Women's HospitalCompletedHematologic Malignancy | CaregiverUnited States
-
University College, Londonbluebird bioActive, not recruitingPost-transplant Lymphoproliferative Disease | Transplant-Related Hematologic MalignancyUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.Active, not recruitingMalignant Solid Neoplasm | Soft Tissue Sarcoma | Recurrent Ovarian Carcinoma | Triple Negative Breast Cancer | Recurrent Osteosarcoma | Refractory Osteosarcoma | Bone Sarcoma | Giant Cell Tumor of Bone | Ovarian Carcinosarcoma | Platinum-Resistant Ovarian Carcinoma | Dedifferentiated Chondrosarcoma | Malignancy... and other conditionsUnited States
-
Hexin (Suzhou) Pharmaceutical Technology Co., LtdWuhan Union Hospital, ChinaCompleted
-
AstraZenecaActive, not recruitingExtensive-stage Small Cell Lung CancerCanada, Germany, Italy, Czechia, Turkey, Bulgaria
-
Soroka University Medical CenterCompletedHematologic Malignancy
-
Mayo ClinicCompleted
-
University Hospital TuebingenActive, not recruitingSolid Tumor | Influenza | SARS-CoV-2 | Hematologic MalignancyGermany
-
University of KhartoumSudan Medical Specialization BoardCompletedIncidence of Thyroid Cancer in Long Standing MNGSudan
-
Geoff HallNational Health Service, United KingdomCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Gynaecological MalignancyUnited Kingdom
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
City of Hope Medical CenterNational Institute on Aging (NIA)Active, not recruitingCancer | Solid Tumor | Hematologic MalignancyUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of California, Los Angeles; Montefiore... and other collaboratorsCompletedSkin Kaposi Sarcoma | Recurrent Kaposi SarcomaUnited States, Uganda, South Africa
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCastleman Disease | Lymphangioleiomyomatosis | Digestive System Carcinoma | Malignant Neoplasm | Recurrent Breast Carcinoma | Recurrent Thyroid Gland Carcinoma | Metastatic Urothelial Carcinoma | Malignant Female Reproductive System Neoplasm | Neurofibromatosis Type 2 | Recurrent Adult Soft Tissue Sarcoma and other conditionsUnited States
-
Tampere University HospitalHelsinki University Central Hospital; Tampere University; University of Eastern... and other collaboratorsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyActive, not recruitingAbdominal Malignancy | Pelvic MalignancyUnited States
-
AstraZenecaActive, not recruitingCancer | TumorUnited States, Netherlands, United Kingdom